Washington, DC (PRWEB) July 28, 2010
Telcare, Inc., http://www.telcare.com, was selected as one of a handful of emerging companies to exhibit at this week’s joint meeting of the US Federal Communications Commission and the Food and Drug Administration. Telcare demonstrated its cellular-enabled blood glucose meter and related software (which is currently in clinical trials prior to FDA clearance) to Dr. Margaret Hamburg, FDA Commissioner and Mr. Julius Genochowski, chairman of the FCC.
The Telcare product is unique in that it is the first blood glucose meter to automatically transmit a patient’s glucose readings to the doctor’s electronic medical record and to return a caregiver’s advice to the patient, right on the screen of the meter. While there have been products introduced to transmit such information through cell phones and personal computers, none operates automatically, without further work on the part of the patient and none is able to display feedback from the doctor directly to the patient. The data from Telcare’s prototype meter can also be sent to cell phones of involved family members.
In comments delivered immediately following the demonstration, Commissioner Hamburg stated that
“Innovation in broadband and wireless-enabled medical devices holds significant promise for enhancing health and reducing the costs of health care for all Americans. Examples include wireless sensors that remotely monitor heart rhythm and portable glucose monitoring systems. All Americans should be afforded the opportunity to benefit from medical technology advances with improved broadband and wireless technology.”
Dr. Hamburg was followed by Chairman Genochowski, who said,
“Broadband enables remote medical monitoring – wireless devices can help diabetes patients track their glucose levels, or heart disease patients monitor cardiovascular data.” Broadband can enable access to electronic health records wherever the patient may be and save our nation more than $500 billion over the next 15 years.”
Telcare was represented by Dr. Jonathan Javitt, its CEO and Vice Chairman and Mr. John Dwyer, its Chairman. “We are honored to have been invited to exhibit Telcare’s technology at such a groundbreaking meeting,” said Dr. Javitt, “in our view, this technology demonstrates the intersection of the administration’s focus on health information technology and the administration’s new broadband plan.”
Telcare is committed to creating the very best medical device experience for patients and healthcare professionals. Connecting powerful hardware and innovative software via a “no wires” approach, Telcare’s offerings aim to provide convenient and effective disease management tools. The company’s first diabetes solution, Telcare Blood Glucose Monitoring System, won the People’s Choice Award at CTIA Wireless 2009, Best in Show at MobiTechFest 2009 and was an E-tech Finalist at CTIA Wireless 2010.
For further information, please contact: